Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative bioavailability study of immediate-release versus sustained-release flucytosine under fed conditions
PACTR202211836109661Phase 1Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of flucytosine in mycoses, sponsored by Drugs for Neglected Diseases initiative. Started Nov 2022; status: completed.
02
Drugs
flucytosine
03
Conditions
mycoses
Beyond the preview
Go deeper on PACTR202211836109661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202211836109661.